Triglycerides and the Risk of Coronary Heart Disease 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies
Nadeem Sarwar;John Danesh;Gudny Eiriksdottir;Gunnar Sigurdsson.
Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysis
S. Matthijs Boekholdt;Benoit J. Arsenault;Samia Mora;Terje R. Pedersen.
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: A meta-analysis of statin trials
S. Matthijs Boekholdt;G. Kees Hovingh;Samia Mora;Benoit J. Arsenault.
Journal of the American College of Cardiology (2014)
Body Fat Distribution and Risk of Coronary Heart Disease in Men and Women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk Cohort A Population-Based Prospective Study
Dexter Canoy;S. Matthijs Boekholdt;Nicholas Wareham;Robert Luben.
Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment
John J.P. Kastelein;Wim A. van der Steeg;Ingar Holme;Michael Gaffney.
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
Wim A. van der Steeg;Ingar Holme;S. Matthijs Boekholdt;Mogens Lytken Larsen.
Journal of the American College of Cardiology (2008)
Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals: The EPIC-Norfolk Prospective Population Study
Marijn C. Meuwese;Erik S G Stroes;Stanley L. Hazen;Joram N. van Miert.
Journal of the American College of Cardiology (2007)
Genetic variants influencing circulating lipid levels and risk of coronary artery disease.
Dawn M. Waterworth;Sally L. Ricketts;Kijoung Song;Li Chen.
Arteriosclerosis, Thrombosis, and Vascular Biology (2010)
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.
Danish Saleheen;Robert Scott;Sundas Javad;Wei Zhao.
The Lancet Diabetes & Endocrinology (2015)
The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults : the good the bad and the uncertain : a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011
Kausik K. Ray;John J.P. Kastelein;S. Matthijs Boekholdt;Stephen J. Nicholls.
European Heart Journal (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: